Johnson & Johnson pauses Covid-19 vaccine trial after “unexplained illness”
Drugmaker Johnson & Johnson said Monday it has paused the advanced clinical trial of its experimental coronavirus vaccine because of an unexplained illness in one of the volunteers.
“Based on our strong commitment to safety, all clinical studies conducted by the Janssen Pharmaceutical Companies of Johnson & Johnson have prespecified guidelines. These ensure our studies may be paused if an unexpected serious adverse event (SAE) that might be related to a vaccine or study drug is reported, so there can be a careful review of all of the medical information before deciding whether to restart the study,” the company said.
You may be interested
US: There will be costs if Russia acts against UkrainePanos - Apr 12, 2021
U.S Secretary of State Antony Blinken on Sunday said: “it would be a serious mistake” for China to strike at…
Kikilias: The plan is for vaccinations of healthy people in their 40s to begin in JunePanos - Apr 12, 2021
If everything goes according to plan and deliveries for the second quarter are made on time, vaccinations of healthy people…